Our 48 year old patient with relapsed/refractory DLBCL is referred for consideration of CAR T-cell therapy. She is managed with IVE chemotherapy as a ‘bridging treatment’ and is subsequently admitted for CAR T-cell infusion.
You are the on-call haematology SpR. You are called at 2am regarding our patient. She is 5 days post CAR T-cell infusion, and the SHO on-call is concerned she is ‘septic.’ Current observations are:
SpO2 92% O/A
What would be your next steps in the acute investigation and management of this patient?
Please reply to us (@TeamHaem) on Twitter and always include #TeamHaem to allow others to follow your comments. Please join in the debate and learn about haematological problems along the way. The case will continue to evolve over the coming week so keep checking #TeamHaem on Twitter for more information.
Please note – all cases on TeamHaem are entirely fictional to protect patient confidentiality.
TeamHaem are not a position of authority. It is an educational platform to allow discussion and learning.